BDTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.07%

Insider Buying (Last 12 Months): $20,488,600.00

Insider Selling (Last 12 Months): $167,500.00

Black Diamond Therapeutics Insider Trading History Chart

Black Diamond Therapeutics Share Price & Price History

^$5.26

▼ -0.04 (-0.75%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Black Diamond Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/17/2023	Growth N V Biotech	Major Shareholder	Buy	400,000	$2.34	$936,000.00	8,517,839
7/5/2023	Ali Behbahani	Director	Buy	1,000,000	$5.00	$5,000,000.00	4,448,757
6/30/2023	Growth N V Biotech	Major Shareholder	Buy	1,000,000	$5.00	$5,000,000.00	8,117,839
6/27/2023	David M Epstein	Insider	Sell	25,000	$6.70	$167,500.00	671,423
6/27/2023	Growth N V Biotech	Major Shareholder	Buy	1,740,000	$5.49	$9,552,600.00	7,117,839
10/27/2022	Growth N V Biotech	Major Shareholder	Buy	191,678	$1.87	$358,437.86	5,105,064
10/21/2022	Growth N V Biotech	Major Shareholder	Buy	87,850	$1.51	$132,653.50	4,913,386
10/19/2022	Growth N V Biotech	Major Shareholder	Buy	77,689	$1.32	$102,549.48	4,771,802
6/29/2022	Fang Ni	Insider	Buy	25,000	$2.44	$61,000.00	69,026
4/27/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$2.66	$399,000.00	4,438,402
4/18/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$3.29	$493,500.00	4,138,402
4/12/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$3.42	$513,000.00	3,885,846
5/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$27.42	$111,818.76	12,478
5/3/2021	Christopher D. Roberts	Insider	Sell	2,500	$26.64	$66,600.00	5,700

The only accurate crypto trading system I know …

From Weiss Ratings | Ad

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

Here's what our expert says you should buy before April 14.

SEC Filings (Institutional Ownership Changes) for Black Diamond Therapeutics (NASDAQ:BDTX)

95.47% of Black Diamond Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	1,947,093	$5.47M	0.0%	-0.8%	3.771%
3/1/2024	Goldman Sachs Group Inc.	45,985	$0.13M	0.0%	N/A	0.089%
2/15/2024	Blue Owl Capital Holdings LP	695,000	$1.95M	0.4%	N/A	1.346%
2/15/2024	Barclays PLC	167,246	$0.47M	0.0%	-48.1%	0.324%
2/15/2024	Vanguard Group Inc.	1,947,093	$5.47M	0.0%	-0.8%	3.771%
2/15/2024	Newtyn Management LLC	280,000	$0.79M	0.2%	+36.6%	0.542%
2/15/2024	Occudo Quantitative Strategies LP	18,134	$51K	0.0%	-32.2%	0.035%
2/15/2024	Parkman Healthcare Partners LLC	253,717	$0.71M	0.1%	-51.3%	0.491%
2/15/2024	Bridgeway Capital Management LLC	192,000	$0.54M	0.0%	+51.8%	0.372%
2/14/2024	Bellevue Group AG	8,535,839	$23.99M	0.4%	+4.9%	16.533%
2/14/2024	Verition Fund Management LLC	1,554,629	$4.37M	0.0%	-10.4%	3.011%
2/14/2024	Pale Fire Capital SE	51,100	$0.14M	0.0%	N/A	0.099%
2/13/2024	Northern Trust Corp	109,689	$0.31M	0.0%	+58.0%	0.212%
2/13/2024	Goldman Sachs Group Inc.	45,985	$0.13M	0.0%	N/A	0.089%
2/12/2024	Stifel Financial Corp	111,700	$0.31M	0.0%	+455.7%	0.216%
2/7/2024	Dimensional Fund Advisors LP	110,612	$0.31M	0.0%	+111.7%	0.214%
2/7/2024	Jump Financial LLC	38,888	$0.11M	0.0%	+245.0%	0.075%
1/30/2024	Cornercap Investment Counsel Inc.	82,784	$0.23M	0.0%	N/A	0.160%
12/18/2023	Vanguard Group Inc.	1,963,583	$5.64M	0.0%	+32.6%	3.803%
12/6/2023	Citigroup Inc.	61,348	$0.18M	0.0%	N/A	0.119%
11/21/2023	Walleye Capital LLC	15,409	$44K	0.0%	N/A	0.030%
11/14/2023	Schonfeld Strategic Advisors LLC	149,100	$0.43M	0.0%	N/A	0.289%
11/14/2023	Newtyn Management LLC	205,000	$0.59M	0.1%	+2.5%	0.397%
11/14/2023	Deerfield Management Company L.P. Series C	930,447	$2.67M	0.1%	-48.3%	1.802%
11/13/2023	CHI Advisors LLC	720,000	$2.07M	0.6%	-4.0%	1.395%
11/13/2023	Algert Global LLC	19,820	$57K	0.0%	N/A	0.038%
11/13/2023	Stifel Financial Corp	20,100	$58K	0.0%	N/A	0.039%
11/9/2023	Citigroup Inc.	61,348	$0.18M	0.0%	N/A	0.119%
11/7/2023	Barclays PLC	322,246	$0.93M	0.0%	+159.1%	0.625%
11/7/2023	Jump Financial LLC	11,272	$32K	0.0%	N/A	0.022%
8/22/2023	CHI Advisors LLC	750,000	$3.79M	1.1%	N/A	2.054%
8/15/2023	Point72 Asset Management L.P.	2,000,000	$10.10M	0.0%	N/A	5.478%
8/15/2023	RA Capital Management L.P.	3,525,754	$17.81M	0.3%	+36.1%	9.657%
8/15/2023	Kennedy Capital Management LLC	751,403	$3.80M	0.1%	N/A	2.058%
8/15/2023	Boothbay Fund Management LLC	109,293	$0.55M	0.0%	N/A	0.299%
8/14/2023	Ergoteles LLC	100,000	$0.51M	0.0%	N/A	0.274%
8/14/2023	State of Wisconsin Investment Board	12,100	$61K	0.0%	-41.0%	0.033%
8/14/2023	Bellevue Group AG	8,135,839	$41.09M	0.6%	+50.8%	22.282%
8/14/2023	Rock Springs Capital Management LP	563,233	$2.84M	0.1%	N/A	1.543%
8/14/2023	Driehaus Capital Management LLC	696,969	$3.52M	0.0%	N/A	1.909%
8/11/2023	VR Adviser LLC	353,629	$1.79M	0.3%	N/A	0.969%
8/11/2023	Renaissance Technologies LLC	220,700	$1.12M	0.0%	+1.5%	0.604%
8/11/2023	BlackRock Inc.	1,505,439	$7.60M	0.0%	+99.0%	4.123%
8/11/2023	Artal Group S.A.	2,046,517	$10.34M	0.3%	+24.3%	5.605%
8/11/2023	JPMorgan Chase & Co.	1,080,059	$5.45M	0.0%	+195,562.9%	2.958%
8/10/2023	Monashee Investment Management LLC	170,000	$0.86M	0.2%	N/A	0.466%
8/10/2023	Charles Schwab Investment Management Inc.	14,484	$73K	0.0%	N/A	0.040%
8/8/2023	Candriam S.C.A.	500,009	$2.53M	0.0%	N/A	1.370%
8/4/2023	Maven Securities LTD	187,513	$0.95M	0.0%	N/A	0.514%
8/3/2023	Barclays PLC	124,351	$0.63M	0.0%	+542.6%	0.241%
8/2/2023	Bank of Montreal Can	15,000	$76K	0.0%	N/A	0.041%
7/12/2023	Herbst Group LLC	13,635	$69K	0.0%	N/A	0.037%
7/12/2023	Beacon Capital Management LLC	15,615	$79K	0.0%	-56.2%	0.043%
7/10/2023	AE Wealth Management LLC	15,920	$80K	0.0%	-55.7%	0.044%
5/15/2023	EcoR1 Capital LLC	1,191,094	$2.25M	0.1%	+322.2%	3.263%
5/15/2023	Two Sigma Advisers LP	175,900	$0.33M	0.0%	-17.2%	0.482%
5/15/2023	Two Sigma Investments LP	107,754	$0.20M	0.0%	-25.0%	0.295%
5/12/2023	BlackRock Inc.	756,387	$1.43M	0.0%	-23.9%	2.072%
5/12/2023	Dimensional Fund Advisors LP	25,920	$49K	0.0%	-50.6%	0.071%
5/8/2023	Federated Hermes Inc.	13,185	$25K	0.0%	-91.5%	0.036%
2/15/2023	State of Wisconsin Investment Board	41,200	$74K	0.0%	-36.1%	0.113%
2/15/2023	Millennium Management LLC	524,557	$0.94M	0.0%	+51.2%	1.442%
2/15/2023	Morgan Stanley	31,202	$56K	0.0%	-86.4%	0.086%
2/14/2023	Susquehanna International Group LLP	65,814	$0.12M	0.0%	-30.9%	0.181%
2/14/2023	Two Sigma Investments LP	143,664	$0.26M	0.0%	-30.9%	0.395%
2/14/2023	EcoR1 Capital LLC	282,131	$0.51M	0.0%	N/A	0.776%
2/10/2023	K2 Principal Fund L.P.	158,192	$0.29M	0.0%	-84.7%	0.435%
2/9/2023	Dimensional Fund Advisors LP	52,522	$95K	0.0%	-12.5%	0.144%
1/12/2023	Marquette Asset Management LLC	34,400	$62K	0.0%	N/A	0.095%
11/15/2022	Two Sigma Advisers LP	214,600	$0.36M	0.0%	-20.0%	0.590%
11/15/2022	Two Sigma Investments LP	207,893	$0.35M	0.0%	-20.2%	0.572%
11/15/2022	Vanguard Group Inc.	757,098	$1.28M	0.0%	+13.9%	2.082%
11/15/2022	BlackRock Inc.	1,263,517	$2.14M	0.0%	-0.7%	3.474%
11/14/2022	Renaissance Technologies LLC	217,700	$0.37M	0.0%	-20.0%	0.599%
11/14/2022	Ergoteles LLC	50,347	$85K	0.0%	-54.2%	0.138%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	82,881	$0.14M	0.0%	+572.2%	0.228%
11/10/2022	Dimensional Fund Advisors LP	60,046	$0.10M	0.0%	N/A	0.165%
10/18/2022	Bailard Inc.	21,281	$36K	0.0%	-63.6%	0.059%
10/5/2022	Beacon Capital Management LLC	35,615	$88K	0.0%	+48.4%	0.098%
9/16/2022	Federated Hermes Inc.	159,548	$0.39M	0.0%	-84.6%	0.439%
8/18/2022	Goldman Sachs Group Inc.	102,126	$0.25M	0.0%	-43.6%	0.281%
8/15/2022	Occudo Quantitative Strategies LP	19,807	$49K	0.0%	-27.0%	0.055%
8/15/2022	AQR Capital Management LLC	18,663	$46K	0.0%	+34.4%	0.051%
8/15/2022	State Street Corp	76,384	$0.19M	0.0%	-79.3%	0.210%
8/15/2022	Cubist Systematic Strategies LLC	15,804	$39K	0.0%	+25.8%	0.043%
8/15/2022	Millennium Management LLC	247,540	$0.61M	0.0%	N/A	0.681%
8/13/2022	Renaissance Technologies LLC	272,002	$0.67M	0.0%	+2.8%	0.750%
8/12/2022	Northern Trust Corp	37,838	$93K	0.0%	-80.1%	0.104%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	73,100	$0.18M	0.0%	-79.5%	0.201%
8/11/2022	UBS Group AG	17,599	$44K	0.0%	-15.5%	0.048%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	12,330	$30K	0.0%	N/A	0.034%
8/3/2022	AE Wealth Management LLC	36,385	$90K	0.0%	+45.8%	0.100%
7/27/2022	Bailard Inc.	58,500	$0.14M	0.0%	N/A	0.161%
5/16/2022	Goldman Sachs Group Inc.	181,097	$0.50M	0.0%	+37.0%	0.499%
5/16/2022	PDT Partners LLC	66,168	$0.18M	0.0%	-10.6%	0.182%
5/16/2022	UBS Group AG	20,820	$58K	0.0%	-29.6%	0.057%
5/13/2022	Renaissance Technologies LLC	264,491	$0.73M	0.0%	-31.4%	0.729%
5/13/2022	Bellevue Group AG	3,293,000	$9.12M	0.1%	-4.9%	9.075%
5/13/2022	Northern Trust Corp	189,946	$0.53M	0.0%	-5.7%	0.523%
5/13/2022	Charles Schwab Investment Management Inc.	48,287	$0.13M	0.0%	-19.9%	0.133%

Data available starting January 2016

Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $5.26

$5.17

$5.57

50 Day Range

MA: $4.86

$3.78

$5.74

52 Week Range

Now: $5.26

$1.43

$6.85

Volume

386,460 shs

Average Volume

588,518 shs

Market Capitalization

$272.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.64

Who are the company insiders with the largest holdings of Black Diamond Therapeutics?: Black Diamond Therapeutics' top insider shareholders include:
Growth N V Biotech (Major Shareholder)
Ali Behbahani (Director)
David M Epstein (Insider)
Fang Ni (Insider)
Learn More about top insider investors at Black Diamond Therapeutics.